Introduction
This continues a series of paper-s analyzing the effects of
intravenous ethylene diamine tetraacetic acid (EDTA) therapy (1-13).
Many physicians have successfully used EDTA to treat atherosclerotic
vascular disease (14-16). In particular, this research studied
stenosis at the bifurcation of the common carotid and in the
internal carotid arteries before and after EDTA infusions.
Conclusion
Significant improvement in the treatment of carotid occlusive
disease should be as effective as surgery. The results from this
study demonstrate that EDTA chelation, together with appropriate
nutritional supplements and diet management can significantly
decrease atheromatous plaque and the chance of cerebral infarction,
thus satisfying this requirement.
Moreover, it should be emphasized that the safety of treatment,
repeatedly demonstrated in our studies (1-13), far outweighs the
published risks of endarterectomy (23). If the end result is equal
to, or better than surgery, chelation should be offered as the
preferred treatment.
Dr. Rudolf practices and is a partner
at the McDonagh Medical Center, Inc. in Kansas City, Mo. were Dr.
McDonagh is founder and Miss Barber is Cardiac Director.
Address reprint requests to:
Charles J. Rudolph, D.O., PhD., 2800-A Kendalwood Pkwy, Kansas City,
MO. 64119. (@1991 Human Science Press, Inc. (complete studies on
file)
